| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7465462 | JAZZ PHARMS | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
May, 2020
(3 years ago) | |
Luvox Cr is owned by Jazz Pharms.
Luvox Cr contains Fluvoxamine Maleate.
Luvox Cr has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Luvox Cr are:
- US7465462
Luvox Cr was authorised for market use on 28 February, 2008.
Luvox Cr is available in capsule, extended release;oral dosage forms.
Luvox Cr can be used as treatment of obsessive compulsive disorder treatable with an ssri.
The generics of Luvox Cr are possible to be released after 10 May, 2020.
Drugs and Companies using FLUVOXAMINE MALEATE ingredient
Market Authorisation Date: 28 February, 2008
Treatment: Treatment of obsessive compulsive disorder treatable with an ssri
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of LUVOX CR before it's drug patent expiration?
More Information on Dosage
LUVOX CR family patents
